Zhang et al. reported that fibrauretine in combination with ginsenosides significantly reduced the progression of Alzheimer's disease through upregulation of Bcl-2 and downregulation of activated caspases 3 and 9 [28]. Here, BCL2 is linked to early-onset autosomal dominant Alzheimer disease.